| GC33898-10mM(1mLinDMSO) |
|
1075732-84-1 |
|
0 |
C67H108N18O28S4 |
|
|
|
| GC33897-5mg |
|
5611-51-8 |
Triamcinolone hexacetonide
|
0 |
C30H41FO7 |
|
|
|
| GC33897-10mM(1mLinDMSO) |
|
5611-51-8 |
Triamcinolone hexacetonide
|
0 |
C30H41FO7 |
|
|
|
| GC33896-20mg |
|
68635-50-7 |
Deloxolone ((3β,20β)-3-(3-Carboxy-1-oxopropoxy)olean-9(11)-en-29-oic acid)
|
0 |
C34H52O6 |
|
|
|
| GC33896-10mg |
|
68635-50-7 |
Deloxolone ((3β,20β)-3-(3-Carboxy-1-oxopropoxy)olean-9(11)-en-29-oic acid)
|
0 |
C34H52O6 |
|
|
|
| GC33896-5mg |
|
68635-50-7 |
Deloxolone ((3β,20β)-3-(3-Carboxy-1-oxopropoxy)olean-9(11)-en-29-oic acid)
|
0 |
C34H52O6 |
|
|
|
| GC33896-1mg |
|
68635-50-7 |
Deloxolone ((3β,20β)-3-(3-Carboxy-1-oxopropoxy)olean-9(11)-en-29-oic acid)
|
0 |
C34H52O6 |
|
|
|
| GC33895-10mg |
|
239440-20-1 |
|
0 |
C17H19Cl2N5O2S |
|
|
|
| GC33895-5mg |
|
239440-20-1 |
|
0 |
C17H19Cl2N5O2S |
|
|
|
| GC33895-1mg |
|
239440-20-1 |
|
0 |
C17H19Cl2N5O2S |
|
|
|
| GC33894-1g |
|
5728-52-9 |
Felbinac (4-Biphenylacetic acid)
|
0 |
C14H12O2 |
|
|
|
| GC33894-10mM(1mLinDMSO) |
|
5728-52-9 |
Felbinac (4-Biphenylacetic acid)
|
0 |
C14H12O2 |
|
|
|
| GC33893-20mg |
|
189699-82-9 |
|
0 |
C16H13ClN2O2S |
|
|
|
| GC33893-10mg |
|
189699-82-9 |
|
0 |
C16H13ClN2O2S |
|
|
|
| GC33893-5mg |
|
189699-82-9 |
|
0 |
C16H13ClN2O2S |
|
|
|
| GC33893-1mg |
|
189699-82-9 |
|
0 |
C16H13ClN2O2S |
|
|
|
| GC33892-10mg |
|
1017931-53-1 |
|
0 |
C19H21F6N3O |
|
|
|
| GC33892-5mg |
|
1017931-53-1 |
|
0 |
C19H21F6N3O |
|
|
|
| GC33892-1mg |
|
1017931-53-1 |
|
0 |
C19H21F6N3O |
|
|
|
| GC33890-5mg |
|
22298-29-9 |
Betamethasone 17-benzoate
|
0 |
C29H33FO6 |
|
|
|
